Summary:
Galenos Research is currently screening for a type 2 diabetes study. The study is 26 weeks long with 12 office visits and 3 telephone visits. Qualified subject will be compensated up to $900.00 for time and travel
Qualified Participants Must:
• Be diagnosed with type 2 diabetes for at least 90 days
•
Be using diet/exercise alone or in combination with metformin
Qualified Participants May Receive:
Study drug, labs, ECG, and be seen by qualified staff at no charge.